Status:
COMPLETED
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
Lead Sponsor:
Institut Curie
Conditions:
Sarcoma
Eligibility:
All Genders
Up to 120 years
Brief Summary
RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to canc...
Detailed Description
OBJECTIVES: * To identify and characterize a genetic susceptibility factor to Ewing's sarcoma by performing a Genome-Wide Association Study with as many as possible Ewing sarcoma patients. OUTLINE: ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patients with Ewing sarcoma
- Relatives of Ewing sarcoma patients
- PATIENT CHARACTERISTICS:
- Patients with a fusion genes specific of Ewing Sarcoma
- PRIOR CONCURRENT THERAPY:
- Not applicable
Exclusion
Key Trial Info
Start Date :
January 7 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT01210209
Start Date
January 7 2010
End Date
July 1 2019
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie Hopital
Paris, France, 75005